版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
LUPUS
Vs
INFECTION整理課件Q1.
What
are
the
most
frequentinfectionsinpatientswithSLE?Q2WhicharetheclinicalfactorsinvolvedinthedevelopmentofinfectionsinSLE?Q3HowcantheriskofinfectiouscomplicationsinSLEbereduced?整理課件Q1.
What
are
the
most
frequentinfectionsinpatientswithSLE?整理課件Infectionisresponsibleforapproximately25%ofalldeathsinpatientswithsystemiclupuserythematosus(SLE)The
main
reason
of
hospitalizationAppearstobehighestwithinthefirst5yearsofdiseaseonset整理課件InfectioninSLEClinRheumatol,2021.33(1):57-63.整理課件CharacteristicsofmajorinfectionsinSLERespiratory
tractsUrinary
tractsSkin
and
soft
tissuesThetypesofinfectionsthatSLEpatientsdevelopedwerethesameasinthegeneralpopulation整理課件Themostfrequentinfectionsinclude:Pneumonia,herpeszostervirus,andurinarytractinfectionArthritisCareRes(Hoboken),2021.67(8):1078-85.CharacteristicsofmajorinfectionsinSLE整理課件RelativerisksofhospitalizationsLupus
compared
with
general
populationArthritisCareRes(Hoboken),2021.67(8):1078-85.整理課件Pathogen
of
infection
in
SLEGram-negativebacilli,gram-positivecocci,fungalandotherbacterialinfectionsaccountedfor39.85%,31.58%,18.80%and9.77%,respectivelyofnosocomialinfections.整理課件Clinicalmanifestations
of
infectionsAtypical
!!!整理課件MycobacteriumtuberculosisThe
prevalence
of
TB
infection
in
SLE:
5-30%Characteristicshigherincidenceratemorefrequentextra-pulmonaryinvolvementmoreextensivepulmonaryinvolvementHighrelapserateeveniftreatedwithprophylacticizoniazidmorecommoninSLErenaltransplantpatientsZandman-Goddard,G.,InfectionsandSLE.Autoimmunity,2021.38(7):473-485.整理課件MycobacteriumtuberculosisTB
maypresentasamimickerofvasculitisTB
maypresentwithskindiseaseposingadiagnosticchallengeAhighindexofsuspicionwillallowprompttreatment.TB.spotData
in
China整理課件ViralinfectionsAcuteviralinfectionsinSLECMV(~50%)parvovirusB19herpessimplexEBVvaricellazostervirushepatitisAamongotherlessfrequentlyreportedviruses整理課件HZVTheannualage-adjustedincidenceofherpeszostervirusinSLEpatientsof12/1000person-yearsMostfrequentlyalate(>5yrs)complicationsofSLEOftenoccurringduringinactivityormildSLEactivity往往皮疹重而神經(jīng)系統(tǒng)表現(xiàn)輕潰瘍性角膜炎耳帶狀皰疹,Ramsay-Hunt
syndrome整理課件Cytomegalovirus〔CMV〕CMVinfectionandSLEexacerbationmaybedifficulttodistinguishDevelopmentofSLEmaybetriggeredbyaCMVinfection.ExistingSLEmayundergoanexacerbationfollowingaCMVinfectionCMV
seropositive
VS
overt
clinical
diseaseOver
90%
SLE
pts
are
seropositiveAntigenemia
18-44%Overt
clinical
disease:
uncommon整理課件PneumocystisPneumonia整理課件PneumocystisPneumoniaA
cut
off
for
PCP
prophylaxisin
any
particular
disease:
3.5%?
6%?however,thefrequencyofPCPvariesgreatlyfromdiseasetodisease.GPA>SLE>IIM>RA?()Risk
factorsLow
CD4+
countsLymphocyte<350+GCs
and
cytotoxic
therapyGCs:
meandailydose,cumulativedose,and/orpulsedosing整理課件PneumocystisPneumonia整理課件PneumocystisPneumoniaClinical
ManifestationsHigh
rate
of
co-infection
with
other
OI,
including
CMV,
Aspergillus,
and
Candida
species.High
mortality:
32%(CTD-PCP),
but
only
~1/4
were
solely
attributable
to
PCP
整理課件PneumocystisPneumoniaProposed
PCP
prophylaxis
in
Pts
with
CTD2
or
more
of
the
followingGCs>=20mg/d
for
>4weeksCurrent
use
of
>=2
DMARDsAbsolute
lymphocyte
count=<350
cell/mm3Underlying
ILDTMP-SMZ:85%
reduction
in
PCP
infectionReal
world
survey,
50%
SLE
pts
on
CYC
using
prophylaxia15.88/1W
pts
reports
PCP
infection;
higher
AEs
ratesNot
sufficient
evidence
to
support
universal
use
of
prophylaxia整理課件Q2WhicharetheclinicalfactorsinvolvedinthedevelopmentofinfectionsinSLE?整理課件RiskfactorsforinfectionUseofsteroidseverUseofCYC,
MMF,
CD20
mAbOrgandamageresultingfromseverelupusSeverelupusflaresinvolvingthekidneyorcentralnervoussystemHighSLEdiseaseactivityindex(SLEDAI)Danza,A.andRuiz-Irastorza,G.,Infectionriskinsystemiclupuserythematosuspatients:susceptibilityfactorsandpreventivestrategies.Lupus,2021.22(12):1286-94.整理課件Prednisoneusetobeassociatedwithinfectionrisk,witheach10mgperdayincreaseofprednisoneincreasingtheriskofseriousinfection11-fold.Ruiz-Irastorza,G.,Predictorsofmajorinfectionsinsystemiclupuserythematosus.ArthritisResTher,2021.11(4):R109.整理課件LN:感染高危因素ArthritisRheumatol,2021.67(6):1577-85.整理課件SLE感染高危因素ArthritisRheumatol,2021.67(6):1577-85.整理課件Q3HowcantheriskofinfectiouscomplicationsinSLEbereduced?整理課件For
RheumatistEULAR
recommend
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年全球及中國可吸收三氯生涂層抗菌縫合線行業(yè)頭部企業(yè)市場占有率及排名調(diào)研報告
- 2025年全球及中國超寬帶雷達(dá)傳感器行業(yè)頭部企業(yè)市場占有率及排名調(diào)研報告
- 2025-2030全球阻燃聚乙烯膜行業(yè)調(diào)研及趨勢分析報告
- 飯店房屋租賃合同范文
- 建筑工程掛靠內(nèi)部協(xié)議合同
- 2025佳兆業(yè)集團(tuán)年度低壓柜設(shè)備戰(zhàn)略采購合同
- 虛擬股合伙協(xié)議合同范本
- 2025工程建設(shè)招標(biāo)設(shè)標(biāo)合同條件第1部分
- 直播帶貨商家簽約的合同范本
- 2025房地產(chǎn)委托開發(fā)合同酬金
- 【七上HK數(shù)學(xué)】安徽省蚌埠市固鎮(zhèn)縣2024-2025學(xué)年七年級上學(xué)期1月期末試卷數(shù)學(xué)試題
- 電信網(wǎng)和互聯(lián)網(wǎng)圖像篡改檢測技術(shù)要求與測試方法
- 2025屆江蘇省南京市鹽城市高三一模考試語文試題 課件
- 《水稻生長進(jìn)程》課件
- 2024版企業(yè)高管職務(wù)任命書3篇
- 中國版梅尼埃病診斷指南解讀
- 創(chuàng)業(yè)投資管理知到章節(jié)答案智慧樹2023年武漢科技大學(xué)
- 暨南大學(xué)《經(jīng)濟(jì)學(xué)》考博歷年真題詳解(宏觀經(jīng)濟(jì)學(xué)部分)
- GB/T 8014.1-2005鋁及鋁合金陽極氧化氧化膜厚度的測量方法第1部分:測量原則
- eNSP簡介及操作課件
- 運動技能學(xué)習(xí)與控制課件第七章運動技能的協(xié)調(diào)控制
評論
0/150
提交評論